Tag: Delta plus variant

  • COVID-19: Maharashtra allows under-18 people to visit malls with age proof; state reports ten more Delta Plus variant cases

    By PTI

    MUMBAI: The Maharashtra government on Monday decided to allow those below 18 years of age who are not vaccinated against COVID-19 to visit shopping malls upon displaying the valid age proof.

    The state government has already allowed people who are fully vaccinated to visit shopping malls which can remain open till 10 pm on all days.

    A government order (GO) issued on Monday under “break the chain” guidelines said since vaccination for the population below the age of 18 has not yet started, they need to show documents of their age proof like the Aadhaar card, PAN card issued by the Income Tax department, valid school or college identity card with mention of the date of birth at the entry point of malls.

    All shopping malls are allowed to function till 10 pm on all days provided the customers/citizens visiting the malls and all employees, including managers and housekeeping staff, possess the final vaccination certificate of receiving two doses of the COVID-19 vaccine and that 14 days must have elapsed after the second dose, the GO said.

    All customers need to show their final vaccination certificate with a photo identity proof at the entry point of malls, it said.

    Further relaxing the COVID-19 curbs, the Maharashtra government on Wednesday decided to allow malls, restaurants, spas and gymnasiums to remain open till 10 pm with a 50 per cent capacity on the condition that the entire staff at these establishments has taken both doses of COVID-19 vaccines.

    Shops were also allowed to operate till 10 pm.

    Meanwhile, ten more cases of the Delta plus variant of coronavirus, considered highly infectious, have been detected in Maharashtra, taking their overall tally to 76, the state health department said on Monday.

    Five patients infected with the variant have died so far in the state.

    The health department, in a statement here said, six of the 10 new cases of the Delta plus variant were found in Kolhapur, followed by three in Ratnagiri and one in Sindhudurg.

    All the 10 patients have completely recovered, it said.

    According to the statement, so far the highest patients of Delta plus – at 15 – have been found in Ratnagiri district followed by Jalgaon, Mumbai and Kolhapur districts at 13, 11 and seven cases, respectively.

    Thane and Pune districts have recorded six cases each, Palghar and Raigad districts three each, Nanded, Gondia and Sindhudurg two each and Chandrapur, Akola, Sangli, Nandurbar, Aurangabad and Beed has one case each.

    Of the 76 patients of the Delta plus variant, five – two from Ratnagiri and one each from Mumbai, Beed and Raigad – have died, according to the statement.

    The deceased – three females and two males – were above the age of 65 years and suffering from high-risk illnesses, it said.

    The department stated, “80 per cent of the samples sent for genome sequencing had tested positive for the Delta plus variant (of coronavirus).”

    Of the 76 patients, 39 were in the 19 to 45 age group, 19 in the 46 to 60 age bracket, nine were over 60 years and another nine were under 18, according to the statement.

    Of the total patients – 39 females and 37 males – 10 had taken both the doses of coronavirus vaccines, while 12 others had received only the first shot, according to the department.

    Of the vaccinate patients, two had taken Covaxin and the remaining Covishield, it said.

    Of the total Delta plus patients, 71 have already recovered and 37 of them were without any symptoms or showed mild symptoms, the statement said.

    The state reported 4,145 new coronavirus cases and 100 fresh fatalities on Monday, taking the infection tally to 63,96,805 and the death toll to 1,35,139, a state health department official said.

    Notably, Nandurbar district in North Maharashtra does not have a single active case of coronavirus currently, making it free of the infection for now.

    The official said 5,811 patients were discharged from hospitals across the state in the last 24 hours, taking the cumulative number of recovered cases to 61,95,744.

    Maharashtra now has 62,452 active cases.

    The state has 3,53,129 people in home quarantine and 2,530 in institutional quarantine, according to the official.

    Maharashtra’s COVID-19 recovery rate now stands at 96.86 per cent, while the fatality rate is 2.11 per cent, he said.

    The cumulative number of tests conducted in the state climbed to 5,11,11,895, of which 1,52,165 tests were done in the last 24 hours, the official said.

    Notably, Dhule, Nandurbar, Jalna, Parbhani, Akola and Wardha districts and Dhule, Jalgaon, Bhiwandi Nizampur, Parbhani, Nanded, Amaravati, and Chandrapur municipal corporations did not report any new coronavirus infections in the last 24 hours, he said.

    The official said Ahmednagar district reported the highest new infections at 660 followed by Solapur at 584, while Aurangabad topped the list of fatalities with 36 deaths in the last 24 hours.

    Among the eight regions of Maharashtra, the Pune region reported the highest new cases at 1,799 followed by 600 cases in the Kolhapur region.

    Among the other regions, Nashik reported 769 cases, Mumbai 465, Latur 169, Akola 21, while Aurangabad and Nagpur regions registered 11 infections each, the official said.

    Out of the 100 fatalities, the highest 46 were reported from the Aurangabad region, followed by 19 from the Kolhapur region, he said.

    Significantly, Akola and Nagpur regions did not report any fresh fatality, while the Pune region registered 17 fatalities, Mumbai 11, Nashik five and the Latur region two.

    The official said Mumbai witnessed 195 new COVID-19 cases and three deaths, while Pune city reported 148 infections, but no fresh death.

    Among the 62,452 active cases in the state, Pune district has the highest at 14,610, he said.

    The official said among the 61,95,744 recovered patients across the state, the highest – 10,71,040 – were from Pune district.

    Coronavirus figures for Maharashtra are as follows: Total cases 63,96,805; new cases 4,145; total deaths 1,35,139; total recoveries 61,95,744; active cases 62,452; total tests 5,11,11,895.

  • Delta Plus variant won’t fuel exponential surge in India, only 86 cases detected so far: Centre

    Express News Service

    NEW DELHI: As many as 86 Covid cases with Delta Plus variant have been detected in India so far, with Maharashtra alone reporting 45 cases but the Centre reiterated that interim findings of the epidemiological analysis show that it may not have public health significance beyond Delta variant.

    “From the evidence we have so far, it looks like the Delta Plus variant of the novel coronavirus will not be able to fuel an exponential surge in the number of Covid cases in India,” said SK Singh, director of the National Centre for Disease Control in a press briefing on the pandemic status in India.

    A similar message was presented by VK Paul, member, health, Niti Aayog, who also heads the national Covid task force, who said that given this variant’s geographical spread so far, it is evident that it may not be able to go beyond Delta Plus’s extent of transmission.

    In most states in India now, Delta Plus has been detected in 80-90% of nearly 59,000 samples collected from those infected, which were subjected to whole-genome sequencing under the Centre’s INSACOG project.

    ALSO READ | Covaxin capable of neutralising delta plus variant of Covid-19 too, shows ICMR study

    Delta variant, which has been estimated to be 50-60% more transmissible than Alpha variant, first identified in the UK, and was responsible for the massive second wave in India before spreading out in most parts of the world.  

    Last month, INSACOG had clarified that there is currently no evidence of any new Delta sub-lineage that is of greater concern than delta.

    A pre-print study released by the Indian Council of Medical Research early this month said that Covaxin – the Covid vaccine developed by Bharat Biotech in collaboration with ICMR and its subsidiary National Institute of Virology (NIV) — is effective in providing protection against the Delta Plus variant.

    The findings, however, did suggest that just like in case of Delta Variant, the efficacy of these vaccines is lowered in case of Delta Plus variant.

    On June 22, the Centre for the first time had designated the Delta Plus variant of the novel coronavirus a “variant of concern”.

    As of now, two variants of SARSCoV2, said Singh, are under investigation in India. These include kappa and B 1.617.3, a virus type also called Delta Plus. 

  • 45 cases of delta plus variant of Covid reported in Maharashtra so far: Government

    By PTI

    MUMBAI: A total of 45 cases of the Delta plus variant of coronavirus have been reported in Maharashtra during genome sequencing, the state health department said on Sunday, adding one patient had died.

    At 13, the maximum number of these patients hailed from Jalgaon in north Maharashtra followed by Ratnagiri (11) in the coastal Konkan region.

    “80 percent of the samples sent for genome sequencing had tested positive for the Delta Plus variant (of coronavirus). The 45 patients are from Jalgaon (13), Ratnagiri (11), Mumbai (6), Thane (5), Pune (3), and one each from Palghar, Sindhudurg, Sangli. Nandurbar, Aurangabad, Kolhapur, and Beed,” the department said in a statement.

    Of these 45 samples, information about 35 patients have been taken by the health department.

    One death was reported while the rest of the patients reported mild to medium type symptoms, it said.

    The exact number of samples sent for genome sequencing and the period during which they were analyzed is not mentioned.

    Union Minister of State for Health Bharati Pawar informed Lok Sabha in a written reply on Friday that analysis of the genomic data is a continuous and ongoing process.

    Periodic updates are shared with experts and states and are also regularly made available in the public domain through the media bulletin of INSACOG (Indian SARS-CoV-2 Genomic Consortium).

    States are regularly advised to send samples for genome sequencing and provide clinical data of positive persons to enable greater epidemiological insights to identify the link between the surge in cases at various places to the variants, the minister stated.

    Elaborating on the steps being taken to check the spread of the Delta variant, Pawar had said to monitor the variants of SARS-CoV-2 virus, initially, genomic sequencing was conducted through the National Institute of Virology, Pune.

    Subsequently, the Union government established the INSACOG in December 2020 as a consortium of 10 laboratories of the Ministry of Health, Department of Biotechnology, Indian Council of Medical Research (ICMR) and Council of Scientific and Industrial Research (CSIR).

    The network of INSACOG laboratories has since been increased to 28, Pawar stated.

  • Second wave of COVID-19 not over yet, cannot lower guard: Govt

    Seventy-one districts reported Covid case positivity rate of more than 10 per cent in the week from June 23 to 29, the government said.

  • Not much data on Delta plus variant to suggest it causes more deaths: Delhi AIIMS director

    By ANI
    NEW DELHI: The Director of All India Institute of Medical Sciences (AIIMS), Delhi, Dr Randeep Guleria on Thursday said that there is not much data available on the Delta plus variant to suggest that it is more infective or has a higher rate of mortality.

    He advised that if people follow COVID appropriate behaviour and take the COVID-19 vaccination, then they will be safe against any emerging variant.

    “There isn’t much data on Delta plus variant to suggest it’s more infectious, causing more deaths, or has developed significant immune escape mechanism. But if we follow COVID appropriate behaviour and get vaccinated, we’ll be safe against any of emerging variants,” Dr Guleria told ANI.

    On Doctor’s Day, the AIIMS director also remembered the health care workers who lost their lives during the COVID pandemic.

    “Doctors are fighting for the last one year and we should appreciate their work. We should also remember those who sacrificed their lives. While remembering them, we should create a situation where the cases do not increase further. We should follow COVID appropriate behaviour and should also adopt vaccination so that there should be less strain on the doctors and the hospitals,” he added.

    Dr Guleria also raised the issue of violence against doctors and added that it is demoralising for the medical community.

    “We should appreciate and respect the work doctors are doing and should condemn violence against doctors. It is a very big threat which is demoralising for the medical community,” the AIIMS director said.

  • Punjab extends Covid curbs till July 10 with more relaxations

    By Agencies
    CHANDIGARH: With cases of the Delta Plus variant of Covid-19 surfacing in Punjab, Chief Minister Amarinder Singh on Tuesday extended the Covid restrictions till July 10, with certain more relaxations, including the opening of bars and pubs at 50%t capacity beginning July 1.

    Skill development centres and universities have also been allowed to open conditional to the staff and students having taken at least one dose of the Covid vaccine. IELTS coaching institutes were already allowed to open, subject to students and staff having taken at least one dose of the vaccine.

    Announcing the relaxations at a high-level Covid review meeting, the Chief Minister made it clear that bars and pubs would have to strictly maintain social distancing protocols, and waiters, servers, and other employees should have taken at least one dose of the Covid vaccine.

    He made it clear that it would be the responsibility of the owners to ensure that the conditions are met.

    Expressing satisfaction over the decline in the Covid positivity rate to less than 1%, along with an overall fall in the number of active cases, the Chief Minister noted that the positivity rate in some districts still remained over the 1% mark.

    ALSO READ |  Arvind Kejriwal promises 300 free electricity units, 24×7 supply in Punjab if AAP wins 2022 polls

    Further, the finding of the Delta Plus variant is a matter of concern, making it essential to continue with the curbs, Amarinder Singh said.

    Two cases — in Ludhiana and Patiala — have shown the Delta Plus variant, while in May and June, the Delta variant was most prevalent, he pointed out.

    Of the 198 contacts of the Ludhiana patient traced and tested, one was found positive and the sample has been sent for genome sequencing. In the Patiala case, for which the genome sequencing report was received on June 26, the process of tracing and testing is going on.

    Chief Secretary Vini Mahajan disclosed that genome sampling reports of as many as 489 samples, including 276 sent in April, 100 in May, and 113 in June, are still pending with the central lab.

    She also clarified that the Delta Plus variant was found in samples sent by the state government in May, whose results were submitted by the central labs recently.

    Health Minister Balbir Sidhu suggested a close watch on visitors from countries reporting Delta Plus variant cases.

  • Samples of 60 COVID-19 patients in Indore sent for genome sequencing amid Delta Plus fear

    By PTI
    INDORE: Samples of 60 coronavirus-infected persons from Indore district of Madhya Pradesh have been sent to Delhi for genome sequencing in the wake of at least eight cases of the Delta Plus variant being reported in the state, an official said on Sunday.

    “We have sent samples of 60 infected persons to the National Centre for Disease Control (NCDC) in two slots for genome sequencing,” Dr Sanjay Dixit, dean of the government-run Mahatma Gandhi Memorial Medical College, told PTI.

    No case of Delta Plus variant has been found in the district so far, he said, adding that genome sequencing is aimed at finding out the type of the variant.

    In Indore district, which has a population of 35 lakh, a total of 1.52 lakh people have tested positive for COVID-19 till now, of whom 1,390 have succumbed to the infection.

    Madhya Pradesh Medical Education Minister Vishvas Sarang had earlier said that at least eight cases of Delta Plus variant have been found in the state so far.

    Of them, two patients – one each at Ujjain and Ashok Nagar districts – have died, officials said.

    ALSO WATCH:

  • Uttarakhand issues alert against Delta Plus variant, Covid testing to be ramped up

    By Express News Service
    DEHRADUN: The Uttarakhand state health department has written to all district chief medical officers to stay alert against the Covid-19 Delta Plus variant which has been classified by the Centre as a concern.

    The four-point direction issued by Dr Tripti Bahuguna, director-general of health, directed the CMOs to identify the people suffering from an influenza-like illness (ILU) and severe acute respiratory illness (SARI). They have been asked to send samples for genome sequencing to identify the variant.   

    The institutions also added that Covid-19 testing should be ramped up and all medical facilities ranging from primary health centres to district hospitals must be prepared. The DG in her letter further asked CMOs to encourage Covid-appropriate behaviour among locals. 

    Meanwhile, total active coronavirus cases rose to 2465 in Uttarakhand after the state recorded 82 fresh cases on Sunday.  

  • Punjab govt for aggressive testing, contact tracing to check spread of Delta Plus variant

    By PTI
    CHANDIGARH: Punjab Chief Secretary Vini Mahajan on Sunday issued directions for aggressive testing and contact tracing to check the spread of Delta Plus, a highly infectious variant of COVID-19.

    Two cases of Delta Plus variant have been reported from Ludhiana and Patiala districts of the state.

    The Delta Plus variant has increased transmissibility, stronger binding to receptors of lung cells and potential reduction in monoclonal antibody response.

    Chairing a meeting of the Covid response group here, the chief secretary said a proposal regarding the installation of a whole genome sequencing machine at Government Medical College in Patiala will be taken up by the Medical Education and Research Department and the Punjab Health Systems Corporation (PHSC).

    Reviewing the state’s efforts to thwart the much-anticipated third wave of the pandemic, Mahajan said a draft policy is being prepared to tackle any more possible wave of the infection, according to an official release.

    She also said the ICMR has approved dry swab testing and the state is going to test this method on a trial basis on 1,000 samples.

    The chief secretary asked the health authorities to closely monitor the districts with high positivity rate, besides directing district epidemiologists to further identify pockets which are reporting higher numbers of cases within their respective districts, the release said.

    ALSO WATCH: 

  • Be cautious, don’t panic against COVID’s Delta-plus variant: Doctors

    By PTI
    JAIPUR: Delta-plus variant of coronavirus is highly infectious but there is no need to panic, former ICMR chief, Dr Raman Gangakhedkar said on Sunday.

    With ICMR data showing over 70 per cent of people having developed immunity against coronavirus, the country appears to be heading towards herd immunity but the Delta-plus variant has created a frightening environment, said another doctor in a webinar on Covid.

    Noting the highly infectious nature of the Delta-plus variant, former chief of the Indian Council of Medical Research, Dr Gangakhedkar said a vaccine is also less effective to it.

    Dr Gangakhedkar, however, added, “There is no need to panic. Researches have shown that mRNA vaccine is likely to be more effective against it.”

    The ex-ICMR chief was part of a group of doctors from different parts of the country who held an in-depth discussion on the possible third wave of coronavirus infection through a webinar organised here on Sunday.

    The organiser of the webinar and a senior dermatologist, Dr Dinesh Mathur said doctors from top medical institutions took part in the conference to share their opinion.

    Dr Gangakhedkar also dispelled the popular misconception that people should avoid taking the Covishield vaccine if they have been given ‘heparin’ to stop bleeding or they have a low blood platelet count.

    He also said the risk of HIV infection can also be found higher in some groups like homosexuals, sex workers and transgenders during the pandemic.

    The former ICMR chief rejected the notion of taking two different vaccines and insisted that one should never take two doses of different vaccines.

    Dr Virendra Singh, a respiratory disease expert, said ICMR data reveal that more than 70 per cent of people have developed immunity against the virus due to infection or vaccine and it seems the country is moving towards herd immunity.

    “But, the Delta-plus variant has created a frightening environment,” he said.

    He, however, counselled caution, saying “instead of being afraid, this pandemic can be avoided with Covid-appropriate behaviour.”

    Dr Raman Sharma of the Department of Medicine of Sawai Man Singh Hospital said it is known from the experience so far that the drug Remdesivir should be used only appropriately and equitably.

    It has also been found from research that drugs like Jack State Inhibitor are proving effective in the treatment of Covid.

    Steroids should also be used at the right time and in the right dosage, he said.

    Other medical science experts who participated in the webinar included Dr Vishwa Mohan Katoch, a former director-general of ICMR, noted microbiologist Dr Nitya Vyas of the Mahatma Gandhi Medical College and chief executive Dr Jaswant Goyal of JNU Medical College, among others.